Clinical Trials · NCT04057261
Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
- Phase
- Phase 3
- Recruitment status
- Withdrawn
- Sponsor
- RWTH Aachen University
- Enrollment
- 0
- Start date
- Nov 2020
- Locations
- 1 site, Germany
- Primary endpoint
- Changes in the metabolomics profile (fold changes) between Liraglutide treatment group and placebo group after 1 and 3 months